1·There is no evidence to support the role of ribavirin as post-exposure prophylactic treatment for Lassa fever.
尚无证据支持利巴韦林作为拉沙热暴露后预防性治疗的作用。
2·Would it be beneficial for patients to extend treatment when the dosage of ribavirin is reduced?
当利巴韦林的用量减少了的时候，延长治疗对所有患者都有益处么。
3·Hepatology Digest: Your previous research showed that minor ribavirin dose reductions to manage adverse events to not appear to adversely affect SVR unless cumulative exposure is less than 60%.
《国际肝病》：您以前的研究表明，利巴韦林用量的微小减少不会明显影响持续病毒应答率，除非剂量累计减少60%以上。
4·In addition to the standard treatment with interferon and ribavirin, some studies have shown higher success rates when the antiviral drug amantadine (Symmetrel) is added to the regimen.
除了干扰素和利巴韦林标准治疗方法，许多研究表明当一种抗病毒的药物金刚烷胺(盐酸金刚烷胺)被加入到病人的生活中后，会产生一种较高的成功率。
5·Through static and dynamic experiments of resin adsorption, the preferable technical conditions of reclaiming ribavirin by LSD-311 resin are ascertained.
通过树脂静态、动态吸附实验，确定了LSD - 311树脂柱吸附分离回收利巴韦林的工艺条件。